CARUSO JAMES V Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$344,797.11
Insider Sells Quantity
1
Insider Sells Sum
$40,704.80

Insider Activity of CARUSO JAMES V

According to the SEC Form 4 filings, CARUSO JAMES V, being in a position of

  1. Chief Executive Officer at Cellectar Biosciences, Inc.,
    оver the last 12 months, has bought 8680 shares for $24,998, and sold 0 shares,
    over all time since 2015-11-18, has bought 189453 shares for $419,696, and sold 34000 shares for $40,705.

Biography of CARUSO JAMES V

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$24,9981100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2026-05-07PurchaseCellectar Biosciences, Inc.
CLRB
Chief Executive Officer
8,680
0.2373%
$2.88$24,998-24.09%
2025-07-02PurchaseCellectar Biosciences, Inc.
CLRB
Chief Executive Officer
10,000
0.0229%
$4.99$49,900-30.02%
2021-03-04PurchaseCellectar Biosciences, Inc.
CLRB
President and CEO
5,100
0.0103%
$1.70$8,659-43.68%
2020-12-28PurchaseCellectar Biosciences, Inc.
CLRB
President and CEO
37,037
0.1219%
$1.35$50,000-41.79%
2020-06-05PurchaseCellectar Biosciences, Inc.
CLRB
President and CEO
21,740
0.1583%
$1.15$24,892+26.32%
2018-11-30PurchaseCellectar Biosciences, Inc.
CLRB
President and CEO
1,000
0.0345%
$2.28$2,282-4.93%
2018-03-12SaleCellectar Biosciences, Inc.
CLRB
President and CEO
34,000
0.2018%
$1.20$40,705-77.08%
2016-04-20PurchaseCellectar Biosciences, Inc.
CLRB
President and CEO
93,896
2.7302%
$2.58$242,252+12.2%
2015-11-24PurchaseCellectar Biosciences, Inc.
CLRB
President and CEO
2,000
0.0249%
$1.30$2,604-75.49%
2015-11-20PurchaseCellectar Biosciences, Inc.
CLRB
President and CEO
2,000
0.0233%
$1.16$2,319-73.79%
2015-11-19PurchaseCellectar Biosciences, Inc.
CLRB
President and CEO
4,000
0.0555%
$1.50$6,000-75.79%
2015-11-18PurchaseCellectar Biosciences, Inc.
CLRB
President and CEO
4,000
0.0519%
$1.45$5,790-76.54%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.